Skip to main content

Table 3 Cox-regression analysis on total mortality

From: Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?

  Univariate OR, 95 CI P Multivariate OR, 95 CI P
Cox-regression analysis of comorbid diseases on total mortality
Age 1.07 (1.06–1.08)  < 0.001 1.07 (1.06–1.08)  < 0.001
Gender (female) 0.61 (0.52–0.70)  < 0.001 0.61 (0.52–0.70)  < 0.001
HT 1.93 (1.66–2.24)  < 0.001 0.99 (0.84–1.18) 0.973
DM 1.18 (1.01–1.38) 0.042 1.07 (0.91–1.26 0.369
CAD 1.63 (1.40–1.91)  < 0.001 0.94 (0.79–1.12) 0.537
HF 2.44 (1.95–3.07)  < 0.001 1.36 (1.05–1.76) 0.018
COPD 2.10 (1.77–2.48)  < 0.001 1.25 (1.05–1.49) 0.009
CVE 1.53 (1.03–2.29) 0.034 0.91 (0.61–1.37) 0.676
CRF 2.36 (1.73–3.23)  < 0.001 1.80 (1.31–2.47)  < 0.001
AF 2.52 (2.21–2.87)  < 0.001 1.56 (1.35–1.79)  < 0.001
Cox-regression analysis of comorbid diseases and AF types on total mortality
Age 1.07 (1.06–1.08)  < 0.001 1.07 (1.06–1.08)  < 0.001
Gender (female) 0.61 (0.52–0.70)  < 0.001 0.61 (0.52–0.70)  < 0.001
HT 1.93 (1.66–2.24)  < 0.001 0.99 (0.84–1.18) 0.973
DM 1.18 (1.01–1.38) 0.042 1.07 (0.91–1.26 0.369
CAD 1.63 (1.40–1.91)  < 0.001 0.94 (0.79–1.12) 0.537
HF 2.44 (1.95–3.07)  < 0.001 1.36 (1.05–1.76) 0.018
COPD 2.10 (1.77–2.48)  < 0.001 1.25 (1.05–1.49) 0.009
CVE 1.53 (1.03–2.29) 0.034 0.91 (0.61–1.37) 0.676
CRF 2.36 (1.73–3.23)  < 0.001 1.80 (1.31–2.47)  < 0.001
Pre-existing AF 1.90 (1.48–2.45)  < 0.001 1.08 (0.83–1.43) 0.539
NOAH 6.90 (5.24–9.08)  < 0.001 2.98 (2.24–3.96)  < 0.001
  1. Abbreviations: HT hypertension, DM diabetes mellitus, CAD coronary artery disease, HF heart failure, COPD chronic obstructive pulmonary disease, CVE cerebrovascular event, CRF chronic renal failure, AF atrial fibrillation, NOAF new-onset atrial fibrillation